These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24576746)

  • 1. Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease.
    Faria MC; Gonçalves GS; Rocha NP; Moraes EN; Bicalho MA; Gualberto Cintra MT; Jardim de Paula J; José Ravic de Miranda LF; Clayton de Souza Ferreira A; Teixeira AL; Gomes KB; Carvalho Md; Sousa LP
    J Psychiatr Res; 2014 Jun; 53():166-72. PubMed ID: 24576746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
    Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
    J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers.
    Barbosa IG; Rocha NP; Huguet RB; Ferreira RA; Salgado JV; Carvalho LA; Pariante CM; Teixeira AL
    J Affect Disord; 2012 Mar; 137(1-3):151-5. PubMed ID: 22252095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment and BDNF serum levels.
    Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
    Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.
    Angelucci F; Spalletta G; di Iulio F; Ciaramella A; Salani F; Colantoni L; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Bossù P
    Curr Alzheimer Res; 2010 Feb; 7(1):15-20. PubMed ID: 20205668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
    Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
    Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer's disease.
    Voigt RM; Raeisi S; Yang J; Leurgans S; Forsyth CB; Buchman AS; Bennett DA; Keshavarzian A
    PLoS One; 2021; 16(3):e0240342. PubMed ID: 33661922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer's disease.
    Coelho FG; Vital TM; Stein AM; Arantes FJ; Rueda AV; Camarini R; Teodorov E; Santos-Galduróz RF
    J Alzheimers Dis; 2014; 39(2):401-8. PubMed ID: 24164734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
    Dursun E; Gezen-Ak D; Hanağası H; Bilgiç B; Lohmann E; Ertan S; Atasoy İL; Alaylıoğlu M; Araz ÖS; Önal B; Gündüz A; Apaydın H; Kızıltan G; Ulutin T; Gürvit H; Yılmazer S
    J Neuroimmunol; 2015 Jun; 283():50-7. PubMed ID: 26004156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
    Qin XY; Cao C; Cawley NX; Liu TT; Yuan J; Loh YP; Cheng Y
    Mol Psychiatry; 2017 Feb; 22(2):312-320. PubMed ID: 27113997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amyloid-β oligomers and soluble tumor necrosis factor receptors as potential biomarkers of AD.
    Zhang J; Peng M; Jia J
    Curr Alzheimer Res; 2014 May; 11(4):325-31. PubMed ID: 24635842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
    J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.
    Pláteník J; Fišar Z; Buchal R; Jirák R; Kitzlerová E; Zvěřová M; Raboch J
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():83-93. PubMed ID: 24334212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 levels in dementia.
    Konukoglu D; Andican G; Fırtına S; Erkol G; Kurt A
    Acta Neurol Belg; 2012 Sep; 112(3):255-60. PubMed ID: 22740022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.